At the Decision Tree, Thomas Goetz blogs that he is "fearful" that with all the interest by Congress in personal genetic testing that "the FDA will feel obligated to regulate and shut us off from what is rightfully ours." Goetz adds that "this isn't a drug, and this isn't a device — it's information about ourselves" and that it provides consumers with the ability "to take control of their health."
Steve Murphy at Gene Sherpas naturally disagrees. At his blog, he says that issue is not about access to personal genetic data, but rather in the interpretation of that information. In a follow-up post, Murphy adds: "When you get a cholesterol of a blood pressure reading in the United States, you would hope the interpretation you receive is standardized in some way. Further you hope at least the person giving you the interpretation of that data has some sort of licensing to assure quality and accuracy."